One meta-analysis reported a statistically significant increase in risk, whereas the remaining seven showed no significant associations
We believe this reflects the increased proportion of GLP-1 prescriptions among younger non-diabetic individuals
Tirzepatide has been shown to decrease food intake and modulate fat utilization
A GLP-1 pill wouldnt need sophisticated cold-chain distribution and storage, meaning it could be sold in countries that dont have that infrastructure
Feuers RJ, Desai VG, Chen FX, Hunter JD, Duffy PH, Oriaku ET
Heres a simple table to show this: By knowing the B12 concentration and volume, doctors can make treatment plans that fit each patients needs